Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, announced that the European Commission (EC) has approved Rixathon (biosimilar rituximab) for use in Europe.
Archive for Category: "Featured"

Amgen and Allergan submit biosimilar biologics license application for ABP 215 to FDA

Biosimilar trastuzumab, CT-P6, shown to be similar in efficacy and safety to the Herceptin

Sandoz proposed biosimilars adalimumab and infliximab accepted for regulatory review by the European Medicines Agency
